| Title |
Voriconazole versus amphotericin B or fluconazole in cancer patients with neutropenia
|
|---|---|
| Published in |
Cochrane database of systematic reviews, February 2014
|
| DOI | 10.1002/14651858.cd004707.pub3 |
| Pubmed ID | |
| Authors |
Karsten Juhl Jørgensen, Peter C Gøtzsche, Christina S Dalbøge, Helle Krogh Johansen |
| Abstract |
Opportunistic fungal infections are a major cause of morbidity and mortality in neutropenic cancer patients and antifungal therapy is used both empirically and therapeutically in these patients. |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 50% |
| Unknown | 1 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Scientists | 1 | 50% |
| Members of the public | 1 | 50% |
Mendeley readers
The data shown below were compiled from readership statistics for 139 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | <1% |
| Denmark | 1 | <1% |
| Unknown | 137 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 19 | 14% |
| Researcher | 16 | 12% |
| Student > Bachelor | 16 | 12% |
| Other | 13 | 9% |
| Student > Postgraduate | 11 | 8% |
| Other | 27 | 19% |
| Unknown | 37 | 27% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 55 | 40% |
| Pharmacology, Toxicology and Pharmaceutical Science | 9 | 6% |
| Nursing and Health Professions | 8 | 6% |
| Biochemistry, Genetics and Molecular Biology | 6 | 4% |
| Agricultural and Biological Sciences | 5 | 4% |
| Other | 16 | 12% |
| Unknown | 40 | 29% |
Attention Score in Context
This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 April 2021.
All research outputs
#15,228,078
of 25,457,297 outputs
Outputs from Cochrane database of systematic reviews
#10,001
of 11,499 outputs
Outputs of similar age
#122,392
of 237,723 outputs
Outputs of similar age from Cochrane database of systematic reviews
#193
of 222 outputs
Altmetric has tracked 25,457,297 research outputs across all sources so far. This one is in the 38th percentile – i.e., 38% of other outputs scored the same or lower than it.
So far Altmetric has tracked 11,499 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 40.0. This one is in the 12th percentile – i.e., 12% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 237,723 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 47th percentile – i.e., 47% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 222 others from the same source and published within six weeks on either side of this one. This one is in the 12th percentile – i.e., 12% of its contemporaries scored the same or lower than it.